Cargando…

Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma

BACKGROUND: This study was to determine circulating tumor cells (CTCs) and the expression of CXC chemokine receptor type 4 (CXCR4) in primary hepatocellular carcinoma (HCC) and the relationships with prognosis. METHODS: We used an advanced CanPatrol(TM) CTC-enrichment technique to collect CTCs for i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Tao, Mai, Rongyun, Ye, Jiazhou, Chen, Jie, Qi, Lunan, Tang, Juan, Wei, Meng, Zhang, Lianda, Chen, Zhiwei, Tang, Zhihong, Li, Lequn, Wu, Feixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798757/ https://www.ncbi.nlm.nih.gov/pubmed/35117486 http://dx.doi.org/10.21037/tcr.2020.01.14

Ejemplares similares

RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2018)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
por: Liu, Ziyu, et al.
Publicado: (2020)

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors
por: Li, Xingzhi, et al.
Publicado: (2023)

Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
por: Chen, Xinyu, et al.
Publicado: (2021)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma
por: Lin, Yan, et al.
Publicado: (2019)

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
por: Huang, Julu, et al.
Publicado: (2023)

CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis
por: Ye, Linsen, et al.
Publicado: (2019)

Relationship of Circulating CXCR4(+) EPC with Prognosis of Mild Traumatic Brain Injury Patients
por: Lin, Yunpeng, et al.
Publicado: (2017)

Decreased Expression of Long Non-Coding RNA GMDS Divergent Transcript (GMDS-DT) is a Potential Biomarker for Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Duo, et al.
Publicado: (2019)

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2022)

Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma
por: Yang, Xihua, et al.
Publicado: (2023)

The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2023)

Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer
por: Yang, Jihua, et al.
Publicado: (2018)

Altered circulating CCR6(+)and CXCR3(+) T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
por: Liao, Zhonghua, et al.
Publicado: (2021)

Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma
por: Zhou, Jiangmin, et al.
Publicado: (2020)

Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1
por: Tang, Yujun, et al.
Publicado: (2019)

D-dimer to lymphocyte ratio can serve as a potential predictive and prognostic value in colorectal cancer patients with liver metastases
por: Lu, Shaolong, et al.
Publicado: (2023)

Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma
por: Wang, Duo, et al.
Publicado: (2019)

The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia
por: Jasirwan, Chyntia Olivia Maurine, et al.
Publicado: (2020)

Correction to: Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1
por: Tang, Yujun, et al.
Publicado: (2021)

Circulating CXCR5 (+) natural killer cells are expanded in patients with myasthenia gravis
por: Ge, Meng‐Ru, et al.
Publicado: (2023)

Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease
por: Chang, Kun, et al.
Publicado: (2017)

SDF-1α Promotes Chondrocyte Autophagy through CXCR4/mTOR Signaling Axis
por: Li, Jiazhou, et al.
Publicado: (2023)

Role of CCNB1, CENPF, and neutrophils in lung cancer diagnosis and prognosis
por: Tan, Feixiang, et al.
Publicado: (2023)

IL-8-induced CXCR2 down-regulation in circulating monocytes in hepatocellular carcinoma is partially dependent on MAGL
por: Liu, Chong Zhong, et al.
Publicado: (2023)

Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
por: Lu, Zhan, et al.
Publicado: (2023)

Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis
por: Zhou, Zewen, et al.
Publicado: (2021)

CXCR3 predicts the prognosis of endometrial adenocarcinoma
por: Dong, He, et al.
Publicado: (2023)

High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia
por: Tang, Wei, et al.
Publicado: (2020)

CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer
por: BAI, MING, et al.
Publicado: (2016)

TNF‐α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma
por: Sun, Kuang‐Hui, et al.
Publicado: (2016)

CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2015)

Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy
por: Mai, Rong-yun, et al.
Publicado: (2022)

Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma
por: Wang, Xicheng, et al.
Publicado: (2019)

Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma
por: Luo, Tao, et al.
Publicado: (2019)

Correction to: Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1
por: Tang, Yujun, et al.
Publicado: (2020)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Effects of high glucose on proliferation and function of circulating fibrocytes: Involvement of CXCR4/SDF-1 axis
por: Weng, Yingzheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r4dq5skbimqs3rcvv7qs64bl42